Gastro-oesophageal junction: to FLOT or to CROSS?-Reference-Cited by-同舟云学术

Gastro-oesophageal junction: to FLOT or to CROSS?

Published:2019-12-09 Issue:2 Volume:59 Page:233-236
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

van den Ende Tom¹^ORCID,Hulshof Maarten C. C. M.²,van Berge Henegouwen Mark I.³,van Oijen Martijn G. H.¹,van Laarhoven Hanneke W. M.¹

Affiliation:

1. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, The Netherlands;

2. Department of Radiotherapy, Cancer Center Amsterdam, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, The Netherlands;

3. Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1698765

Reference9 articles.

1. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

3. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

4. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

5. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with complete clinical response after neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: A Markov decision analysis of esophagectomy versus active surveillance;The Journal of Thoracic and Cardiovascular Surgery;2024-04

2. The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank;Frontiers in Immunology;2023-10-12

3. Facing adenocarcinoma of distal esophagus and esophagogastric junction: a CROSS versus FLOT propensity score-matched analysis of oncological outcomes in a high-volume institution;Updates in Surgery;2023-03-29

4. Evidence-based approach to the treatment of esophagogastric junction tumors;World Journal of Clinical Oncology;2022-03-24

5. Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?;World Journal of Clinical Oncology;2021-07-24